Exact Mass: 367.0394

Exact Mass Matches: 367.0394

Found 33 metabolites which its exact mass value is equals to given mass value 367.0394, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefaclor

(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H14ClN3O4S (367.0394)


Cefaclor is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibiotic derivative of cephalexin. [PubChem]Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3069 Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3][4].

   

5'-Hydroxymethyl meloxicam

4-hydroxy-N-[5-(hydroxymethyl)-1,3-thiazol-2-yl]-2-methyl-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboximidic acid

C14H13N3O5S2 (367.0297)


5-Hydroxymethyl meloxicam is a metabolite of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is a derivative of oxicam, closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. (Wikipedia)

   

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

3-(4-Methanesulphonylphenyl)-4-phenyl-5-(trifluoromethyl)-1,2-oxazole

C17H12F3NO3S (367.049)


   
   

Maybridge3_006658

Maybridge3_006658

C17H12F3NO3S (367.049)


   
   
   
   

cefaclor

Cefaclor Impurity C

C15H14ClN3O4S (367.0394)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3][4].

   
   
   
   

CAY10404

3-(4-Methylsulphonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

C17H12F3NO3S (367.049)


   

5-Hydroxy Meloxicam

5-Hydroxy Meloxicam

C14H13N3O5S2 (367.0297)


   
   

6,7-Isoquinolinediol,1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydro-, hydrobromide (1:1)

6,7-Isoquinolinediol,1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydro-, hydrobromide (1:1)

C16H18BrNO4 (367.0419)


   

Cefadroxil-d4 (major)

Cefadroxil-d4 (major)

C15H14ClN3O4S (367.0394)


   

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

C17H12F3NO3S (367.049)


CAY10404 is a potent and selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 1 nM and a selectivity index (SI; COX-1 IC50/COX-2 IC50) of >500000. CAY10404 is a potent PKB/Akt and MAPK signaling pathways inhibitor and induces apoptosis in non-small cell lung cancer (NSCLC) cells. CAY10404, a diarylisoxazole, has good analgesic, anti-inflammatory, and anti-cancer activities[1][2][3].

   

5-[1-(Benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole

5-[1-(Benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole

C18H13N3O2S2 (367.0449)


   

N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)benzamide

N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)benzamide

C16H9ClF3N3O2 (367.0335)


   
   

6-hydroxy-7,10-diketo-3-O-methyl-pre-bikaverin

6-hydroxy-7,10-diketo-3-O-methyl-pre-bikaverin

C19H11O8- (367.0454)


   

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

C18H13N3O2S2 (367.0449)


   

[3-(2-Furanyl)-5-(phenylmethylthio)-1,2,4-triazol-1-yl]-thiophen-2-ylmethanone

[3-(2-Furanyl)-5-(phenylmethylthio)-1,2,4-triazol-1-yl]-thiophen-2-ylmethanone

C18H13N3O2S2 (367.0449)


   

N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide

N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide

C15H14ClN3O4S (367.0394)


   

3-(2-iodophenoxy)-N-methyl-3-phenyl-1-propanamine

3-(2-iodophenoxy)-N-methyl-3-phenyl-1-propanamine

C16H18INO (367.0433)


   

(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H14ClN3O4S (367.0394)


   

3,6-dihydroxy-2-(3-methoxyphenyl)-7-sulinooxy-3,4-dihydro-2H-chromen-5-olate

3,6-dihydroxy-2-(3-methoxyphenyl)-7-sulinooxy-3,4-dihydro-2H-chromen-5-olate

C16H15O8S- (367.0488)


   

4,5-dihydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide

4,5-dihydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide

C14H13N3O5S2 (367.0297)


   

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

C12H10N5O7P-2 (367.0318)


   

(3S)-5-bromospiro[1H-indole-3,1-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one

(3S)-5-bromospiro[1H-indole-3,1-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one

C18H14BrN3O (367.032)


   

5-Hydroxymethyl meloxicam

5-Hydroxymethyl meloxicam

C14H13N3O5S2 (367.0297)


   

5,6,18,19-tetrahydroxy-9,15-dioxa-12-azapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1(13),2(11),3(8),4,6,16(21),17,19-octaene-10,14-dione

5,6,18,19-tetrahydroxy-9,15-dioxa-12-azapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1(13),2(11),3(8),4,6,16(21),17,19-octaene-10,14-dione

C18H9NO8 (367.0328)